Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BLFS
NTLA
Add up to 3 more stocks
BLFS
BioLife Solutions, Inc.
0.00%
$38.610.00Delayed quote: Oct 5, 2026, 4:00 PM EDT
Market Cap
$1.89B
52W Range
$17.86 - $39.76
NTLA
Intellia Therapeutics, Inc.
-3.69%
$12.28-0.47Delayed quote: Oct 6, 2026, 10:45 AM EDT
Market Cap
$1.72B
52W Range
$7.95 - $28.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 37.72 | N/A |
| Forward P/E | 64.35 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.49 | 2.36 |
| P/S Ratio | 18.35 | 28.83 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 170.26 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 64.5% | 76.5% |
| Operating Margin | -1.1% | -651.7% |
| Net Margin | 49.1% | -672.2% |
| ROE | 12.0% | -55.0% |
| ROA | 11.3% | -46.7% |
| ROIC | 1.7% | -54.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 9.69 | 6.65 |
| Quick Ratio | 7.14 | 6.65 |
| Debt/Equity | 0.04 | 0.10 |
| Interest Coverage | -0.40 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.